October 22-26th, 2018

World Investment Forum 2018 - Geneva, Switzerland

The World Investment Forum will take place from 22 to 26 October 2018, at the Palais des Nations in Geneva, the United Nations Headquarters in Europe and an international business, economic development and diplomacy hub.

Organized under the overall theme Investing in Sustainable Development, the Forum will address global challenges for international investment in the new era of globalization and industrialization. Investment stakeholders will gather to brainstorm solution-oriented initiatives and build global partnerships to advance prosperity for all.

As part of the UNCTAD/WHO event on Fostering investment in the development of new antibacterial treatments, Dr. Gitzinger will be speaking at the second panel: Researchers and industry: Capacities and challenges

October 25-26, 2018

World Anti-Microbial Resistance Congress, Washington DC, USA

Dr. Gitzinger will be speaking October 26th at 14:00 at the Congress in Washington, DC. 

The Title: Composite endpoints – the way to FDA approval for non-traditional antibiotics requires new thinking around endpoints in clinical trials. Are composite endpoints a way forward?

The Agenda can be seen at this link. The Conference will be addressing 4 key areas:

  • Antibiotic R&D
  • Diagnostics
  • Antimicrobial Stewardship
  • Innovation Showcase

October 17-20, 2018

21st-Century Drug Discovery & Development for Global Health

Please join us at the Keystone Symposia in Berlin where Marc Gitzinger will be speaking. See http://www.keystonesymposia.org/18S3 for more details.